KL, klotho, 9365

N. diseases: 332; N. variants: 20
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0011881
Disease: Diabetic Nephropathy
Diabetic Nephropathy
0.300 AlteredExpression disease BEFREE The aim of our study was to show the relationship between the levels of s-Klotho and tubular injury in patients with diabetic kidney disease (DKD), using as tubular injury marker the kidney injury molecule-1 (KIM-1). 30396700 2020
CUI: C0011881
Disease: Diabetic Nephropathy
Diabetic Nephropathy
0.300 Biomarker disease BEFREE Moreover, klotho attenuated diabetic nephropathy in db/db mice, which was also associated with inhibition of the Wnt/β-catenin pathway and RAAS. 30784349 2020
CUI: C0011881
Disease: Diabetic Nephropathy
Diabetic Nephropathy
0.300 Biomarker disease BEFREE In summary, miR-199a-5p from HSA-stimulated HK-2 cell-derived EVs induces M1 polarization by targeting the Klotho/TLR4 pathway and further accelerates the progression of DKD. 31208912 2019
CUI: C0011881
Disease: Diabetic Nephropathy
Diabetic Nephropathy
0.300 PosttranslationalModification disease BEFREE And Klotho gene deficiency enhances the phosphorylation of mammalian target of rapamycin (mTOR), resulting in exacerbating streptozotocin-stimulated diabetic glomerular injury and promoting the progression of early diabetic kidney disease (DKD). 29890551 2019
CUI: C0011881
Disease: Diabetic Nephropathy
Diabetic Nephropathy
0.300 Biomarker disease BEFREE Klotho inhibits PKCα/p66SHC-mediated podocyte injury in diabetic nephropathy. 31207271 2019
CUI: C0011881
Disease: Diabetic Nephropathy
Diabetic Nephropathy
0.300 Biomarker disease BEFREE Sustained Klotho delivery reduces serum phosphate in a model of diabetic nephropathy. 30605400 2019
CUI: C0011881
Disease: Diabetic Nephropathy
Diabetic Nephropathy
0.300 Biomarker disease BEFREE These results also showed that klotho might be used as a unique molecular target for the treatment of diabetic nephropathy. 30668400 2019
CUI: C0011881
Disease: Diabetic Nephropathy
Diabetic Nephropathy
0.300 Biomarker disease BEFREE Effects of Pentoxifylline on Soluble Klotho Concentrations and Renal Tubular Cell Expression in Diabetic Kidney Disease. 29866645 2018
CUI: C0011881
Disease: Diabetic Nephropathy
Diabetic Nephropathy
0.300 AlteredExpression disease BEFREE Corrigendum: Atrasentan increased the expression of klotho by mediating miR-199b-5p and prevented renal tubular injury in diabetic nephropathy. 29623952 2018
CUI: C0011881
Disease: Diabetic Nephropathy
Diabetic Nephropathy
0.300 Biomarker disease BEFREE However, the roles of P2X<sub>7</sub> and klotho in the progression of diabetic nephropathy are still unclear. 29541926 2018
CUI: C0011881
Disease: Diabetic Nephropathy
Diabetic Nephropathy
0.300 AlteredExpression disease BEFREE Vitamin D may have a valuable role in the renal protective effect from DN, this may occur via expression of its VDR, Klotho and blocking renin-angiotensin activation, so vitamin D should be considered as a target in renal prophylactic measures against DN. 29308676 2018
CUI: C0011881
Disease: Diabetic Nephropathy
Diabetic Nephropathy
0.300 AlteredExpression disease BEFREE Our study suggests that SDX may prevent the progression of DKD at the early stage by upregulating renal klotho expression, which inhibits the tubulointerstitial injury induced by oxidative stress. 28929120 2017
CUI: C0011881
Disease: Diabetic Nephropathy
Diabetic Nephropathy
0.300 Biomarker disease BEFREE Klotho can attenuate renal fibrosis in part by inhibiting TGF-β1/Smad3 signaling in DKD. 28411025 2017
CUI: C0011881
Disease: Diabetic Nephropathy
Diabetic Nephropathy
0.300 Biomarker disease BEFREE Treated the mice and HK-2 cells with atrasentan, and we then investigated whether and how miR-199b-5p and Klotho were involved in preventing renal tubular injury in DN. 26813039 2016
CUI: C0011881
Disease: Diabetic Nephropathy
Diabetic Nephropathy
0.300 AlteredExpression disease BEFREE We found that klotho protein overexpression attenuates renal hypertrophy and glomerular injury in this mouse model of diabetic nephropathy. 26586006 2016
CUI: C0011881
Disease: Diabetic Nephropathy
Diabetic Nephropathy
0.300 Therapeutic disease RGD Taken together, oral administration of TZD may improve STZ-induced diabetic nephropathy due to restoration of the expression of klotho axis through an increase in PPARγ expression without changing blood glucose in rats. 24136780 2014
CUI: C0011881
Disease: Diabetic Nephropathy
Diabetic Nephropathy
0.300 AlteredExpression disease BEFREE Thus, α-Klotho expression was decreased in distal convoluted tubules in diabetic nephropathy in humans and mice. 22217880 2012